Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin for Preservation of Beta-Cell Function in Type 2 Diabetes
NCT00420511Phase 2Completed
- Sponsor
- Mount Sinai Hospital
- Start
- Jan 2007
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Mount Sinai Hospital. Started Jan 2007; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00420511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00420511.